Beijing, June 29, 2021 (Agency) Two doses of CoronaVac, a Covid-19 vaccine manufactured by Chinese firm Sinovac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a results of phase 1/2 clinical trial published in The Lancet Infectious Diseases journal. China earlier this month, authorised the emergency … Continue reading China’s Coronavac safe for upto 3-yr-old: Lancet